Skip to main content

Table 1 Patient characteristics

From: Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma

Patient characteristics   %
Number   
Total included 36 100
Assessable for response 36 100
Sex   
Male 26 72
Female 10 28
Age   
Median 62  
Range 25-75  
Performance status   
0 16 44.4
1 16 44.4
2 4 11.1
MSKCC criteria   
Low risk 2 5.6
Intermediate risk 15 41.7
High risk 19 48.7
Previous treatments   
Nephrectomy 30 83.3
Cytokines 15 41.7
Radiotherapy 10 27.8
Metastatic sites   
Lung 24 66.7
Bone 10 27.8
Lymph nodes 7 19.4
Liver 4 11.1
Local relapse 2 5.6
Other 5 13.9
\